10-Q: Scotts Miracle-Gro Reports Q2 2025 Results: Net Income Surges Despite Sales Dip

Sentiment:

Quarterly Report


Scotts Miracle-Gro's Q2 2025 net income increased significantly year-over-year, driven by improved gross margins and reduced restructuring charges, despite a decrease in net sales.

Capital raiseAs part of its contingency planning to address potential future circumstances that could result in noncompliance, the Company has contemplated alternative plans that are subject to market conditions and not in our control, including, among others, discussions with its lenders to amend the terms of its financial covenants under the Sixth A&R Credit Agreement and generating cash by completing other financing transactions, which may include issuing equity.
Better than expectedNet income and gross margin improved year-over-year, indicating better financial performance despite a decrease in net sales.

Summary

  • Scotts Miracle-Gro reported net sales of $1,421.0 million for the three months ended March 29, 2025, a 6.8% decrease compared to $1,525.4 million for the same period last year.
  • Net income for the quarter was $217.5 million, or $3.72 per diluted share, compared to $157.5 million, or $2.74 per diluted share, in the prior year.
  • The company's gross margin rate increased to 38.6% from 30.4% year-over-year.
  • Selling, general, and administrative expenses increased by 5.4% to $188.3 million.
  • The Hawthorne segment experienced a 50.8% decrease in net sales, while the U.S. Consumer segment saw a 4.9% decrease.
  • The company's leverage ratio was 4.41 at March 29, 2025, and the fixed charge coverage ratio was 1.45 for the twelve months ended March 29, 2025.
  • Scotts Miracle-Gro expects to remain in compliance with financial covenants under its Sixth A&R Credit Agreement.
  • The company's effective tax rate for the six months ended March 29, 2025, was 27.8%.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While sales are down, net income is up and the company is managing its debt covenants. The challenges in the Hawthorne segment and the potential need for restructuring or equity issuance temper the positive aspects.

Positives

  • Net income increased significantly due to improved gross margin and lower impairment and restructuring charges.
  • The company is in compliance with all applicable covenants in its debt agreements.
  • Interest expense decreased due to lower average borrowings and a decrease in the weighted average interest rate.
  • U.S. Consumer Segment Profit was $392.5 in the second quarter of fiscal 2025, an increase of 1.8% from second quarter of fiscal 2024 Segment Profit of $385.7.

Negatives

  • Net sales decreased by 6.8% due to lower volume and pricing.
  • The Hawthorne segment experienced a substantial decline in net sales.
  • Selling, general, and administrative expenses increased.
  • Cash used in operating activities increased significantly.

Risks

  • The oversupply of cannabis is expected to continue to adversely impact the Hawthorne segment.
  • Macroeconomic conditions, geopolitical uncertainty, and global supply chain disruptions could impact operational and financial performance.
  • A covenant violation may result in an event of default under the Sixth A&R Credit Agreement and Senior Notes.
  • The company does not have sufficient cash on hand or available liquidity that can be utilized to repay these outstanding amounts in the event of default.

Future Outlook

The company expects the oversupply of cannabis to continue to adversely impact its Hawthorne segment. Based on projections, the company expects to remain in compliance with the financial covenants under the Sixth A&R Credit Agreement.

Industry Context

The report highlights the challenges faced by the Hawthorne segment due to the oversupply of cannabis, reflecting broader issues in the cannabis industry related to increased licensing and capital investment.

Comparison to Industry Standards

  • The document does not provide specific comparisons to industry standards or competitors.
  • Without more information, it's difficult to assess Scotts Miracle-Gro's performance against industry benchmarks.
  • A deeper dive into competitor results and industry trends would be needed for a comprehensive comparison.

Legal Proceedings

  • The company is involved in several legal actions with various governmental agencies related to environmental matters.
  • The company is a defendant in a number of cases alleging injuries that the lawsuits claim resulted from exposure to asbestos-containing products.
  • A purported shareholder filed a lawsuit in the United States District Court for the Southern District of Ohio (Case No. 2:24-cv-03132) on behalf of a proposed class of purchasers of Common Shares between November 3, 2021, and August 1, 2023.
  • On July 26, 2024, another purported shareholder filed a lawsuit in the United States District Court for the Southern District of Ohio (Case No. 2:24-cv-03766) on behalf of a proposed class of purchasers of Common Shares between June 2, 2021, and August 1, 2023.
  • Beginning in July 2024, purported shareholders filed a series of shareholder derivative lawsuits in state and federal courts in Ohio against certain of the Companys current and former directors and officers.

Stakeholder Impact

  • Shareholders may be impacted by the company's financial performance and compliance with debt covenants.
  • Employees may be impacted by restructuring activities and changes in compensation.
  • Customers may be impacted by changes in pricing and product availability.
  • Suppliers may be impacted by the company's supplier finance program.

Next Steps

  • The company will continue to monitor the impacts of macroeconomic conditions and geopolitical uncertainty.
  • The company will continue to implement restructuring activities to reduce operating expenses and certain cash management strategies.
  • The company may engage in discussions with its lenders to amend the terms of its financial covenants.

Key Dates

DateDescription
December 15, 2016Scotts Miracle-Gro issued $250.0 million of 5.250% Senior Notes due 2026.
October 22, 2019Scotts Miracle-Gro issued $450.0 million of 4.500% Senior Notes due 2029.
March 17, 2021Scotts Miracle-Gro issued $500.0 million of 4.000% Senior Notes due 2031.
August 13, 2021Scotts Miracle-Gro issued $400.0 million of 4.375% Senior Notes due 2032.
April 8, 2022The Company entered into a sixth amended and restated credit agreement (the Sixth A&R Credit Agreement), providing the Company and certain of its subsidiaries with five-year senior secured loan facilities in the aggregate principal amount of $2,500.0.
June 8, 2022The Company entered into Amendment No. 1 to the Sixth A&R Credit Agreement.
October 27, 2023The Company entered into the Master Receivables Purchase Agreement.
July 31, 2023The Company entered into Amendment No. 2 to the Sixth A&R Credit Agreement.
September 1, 2024The Company amended the Master Receivables Purchase Agreement to permit the Company to sell up to $750.0 of available and eligible outstanding customer accounts receivable generated by sales to five specified customers.
December 18, 2024Fluent and THC entered into an exchange and protection agreement.
December 19, 2024Fluent acquired all of the issued and outstanding common shares of RIV Capital Inc.
February 4, 2025Consulting Agreement, dated February 4, 2025, between The Scotts Company LLC and Hanft Ideas LLC.
March 6, 2025The Hagedorn Partnership, L.P., on behalf of Katherine Littlefield, a member of our board of directors, terminated a Rule 10b5-1 trading arrangement.
March 14, 2025The Company sold all of the issued and outstanding shares of capital stock of its formerly wholly-owned subsidiary The Hawthorne Collective, Inc. (THC) to Bad Dog Holdings LLC (BDH).
March 29, 2025End of the fiscal quarter.
May 2, 2025There were 57,715,024 Common Shares outstanding.
May 7, 2025Date of report filing.
September 1, 2025The Master Receivables Purchase Agreement expires.
September 30, 2025The term of the consulting agreement between Hanft Ideas and The Scotts Company LLC will end.
April 8, 2027The Sixth A&R Credit Agreement will terminate.
March 14, 2035The Company may exercise the call option in its sole and absolute discretion, until the earlier of (i) March 14, 2035 and (ii) the date of the consummation of a merger, change in control or consolidation of BDH; or a sale, lease, transfer, exclusive license or other disposition of all or substantially all of the assets of BDH.

Keywords

Scotts Miracle-Gro, financial results, net income, net sales, Hawthorne, U.S. Consumer, gross margin, leverage ratio, debt, cannabis, restructuring, segment profit

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.